McKesson SG&A Expenses 2010-2024 | MCK
McKesson annual/quarterly sg&a expenses history and growth rate from 2010 to 2024. Sg&a expenses can be defined as the sum of all selling, general and administrative expenses.
- McKesson sg&a expenses for the quarter ending December 31, 2024 were $2.028B, a 19.07% decline year-over-year.
- McKesson sg&a expenses for the twelve months ending December 31, 2024 were $8.721B, a 3.43% increase year-over-year.
- McKesson annual sg&a expenses for 2024 were $8.657B, a 11.33% increase from 2023.
- McKesson annual sg&a expenses for 2023 were $7.776B, a 26.2% decline from 2022.
- McKesson annual sg&a expenses for 2022 were $10.537B, a 19.08% increase from 2021.
McKesson Annual SG&A Expenses
(Millions of US $) |
| 2024 |
$8,657 |
| 2023 |
$7,776 |
| 2022 |
$10,537 |
| 2021 |
$8,849 |
| 2020 |
$9,182 |
| 2019 |
$8,437 |
| 2018 |
$8,138 |
| 2017 |
$7,447 |
| 2016 |
$7,379 |
| 2015 |
$7,901 |
| 2014 |
$5,388 |
| 2013 |
$4,110 |
| 2012 |
$3,727 |
| 2011 |
$3,529 |
| 2010 |
$3,312 |
| 2009 |
$3,325 |
McKesson Quarterly SG&A Expenses
(Millions of US $) |
| 2024-12-31 |
$2,028 |
| 2024-09-30 |
$2,503 |
| 2024-06-30 |
$2,001 |
| 2024-03-31 |
$2,189 |
| 2023-12-31 |
$2,506 |
| 2023-09-30 |
$2,092 |
| 2023-06-30 |
$1,870 |
| 2023-03-31 |
$1,964 |
| 2022-12-31 |
$1,903 |
| 2022-09-30 |
$1,950 |
| 2022-06-30 |
$1,959 |
| 2022-03-31 |
$2,531 |
| 2021-12-31 |
$3,105 |
| 2021-09-30 |
$2,669 |
| 2021-06-30 |
$2,232 |
| 2021-03-31 |
$2,224 |
| 2020-12-31 |
$2,291 |
| 2020-09-30 |
$2,237 |
| 2020-06-30 |
$2,097 |
| 2020-03-31 |
|
| 2019-12-31 |
|
| 2019-09-30 |
|
| 2019-06-30 |
|
| 2019-03-31 |
|
| 2018-12-31 |
|
| 2018-09-30 |
|
| 2018-06-30 |
|
| 2018-03-31 |
|
| 2017-12-31 |
|
| 2017-09-30 |
|
| 2017-06-30 |
|
| 2017-03-31 |
|
| 2016-12-31 |
|
| 2016-09-30 |
|
| 2016-06-30 |
|
| 2016-03-31 |
|
| 2015-12-31 |
|
| 2015-09-30 |
|
| 2015-06-30 |
|
| 2015-03-31 |
|
| 2014-12-31 |
|
| 2014-09-30 |
|
| 2014-06-30 |
|
| 2014-03-31 |
|
| 2013-12-31 |
|
| 2013-09-30 |
|
| 2013-06-30 |
|
| 2013-03-31 |
|
| 2012-12-31 |
|
| 2012-09-30 |
|
| 2012-06-30 |
|
| 2012-03-31 |
|
| 2011-12-31 |
|
| 2011-09-30 |
|
| 2011-06-30 |
|
| 2011-03-31 |
|
| 2010-12-31 |
|
| 2010-09-30 |
|
| 2010-06-30 |
|
| 2010-03-31 |
|
| 2009-12-31 |
|
| 2009-09-30 |
|
| 2009-06-30 |
|
| 2009-03-31 |
|
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical & Dental Supplies |
$87.363B |
$308.951B |
|
McKesson Corporation is a health care services and information technology company. McKesson operates through two segments: The Distribution Solutions segment distributes branded and generic pharmaceutical drugs along with other healthcare-related products on a global basis worldwide. The segment also provides practice management, technology, clinical support and business solutions to community-based oncology and other specialty practices. In addition, the segment provides specialty pharmaceutical solutions for pharmaceutical manufacturers including offering multiple distribution channels and study access to oncology physicians. The Technology Solutions segment provides enterprise-wide clinical, patient care, financial, supply chain, and strategic management software solutions. per segment realignment, McKesson reported revenues through four segments: U.S. Pharmaceutical and Specialty Solutions, Internation, Medical-Surgical Solutions and Prescription Technology Solutions.
|
